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ABSTRACT 
 
Aim: To study the clinical profile,  aetiology, precipitating insults of patients presenting with acute on chronic 
liver failure. To study the various predictors of mortality and outcome of acute chronic liver failure. Materials and 
Methods: This prospective observational study was conducted on 50 consecutive patients of acute on chronic 
liver failure f o r  a  period of 2 years. Results: ACLF has a predominant male preponderance with a male: 
female ratio of 5.25:1. The mean age of patients presenting with ACLF was 40.88 ± 1.1 yrs. Most common cause 
of underlying liver disease is alcoholic liver disease (76 %) followed by hepatitis B (6 %). Among the alcoholic 
liver disease super added alcoholic hepatitis is the most common (36.8%) cause followed by acute hepatitis E 
(18.4%). Among patients with chronic hepatitis B, reactivation of hepatitis B is the most common cause. The cause 
for acute deterioration could not be found in about 13.2% of patients. Higher mean Blood urea, Creatinine, 
prothrombin time, INR and CRP was significantly higher in the patients who died compared to patients who 
survived (P<0.05.). SOFA score is a better predictor of mortality than MELD and CTP score. SOFA score of 7.5 
has a sensitivity of 81.5% and specificity of 91.3 % in predicting mortality. MELD score of 36 has a sensitivity of 
25.9% and specificity of 100 % in predicting mortality. CTP score of 11.5 has a sensitivity of 81.5% and 
specificity of 87 % in detecting mortality. Most common cause of death is the multi organ failure. Increasing 
number of organ failures is associated with increasing risk of death. Conclusion: ACLF is characterized by 
rapidly deteriorating course in a previously diagnosed or undiagnosed chronic liver disease with a potential for 
reversibility. It has generally been shown that MELD and SOFA scores are better predictors of mortality than 
Child score and APACHE score 
Key words: Chronic liver failure, Sequential organ failure, Maddrey's Discriminant function. 
Introduction 
Acute on chronic liver failure (ACLF) is an acute 
deterioration of a chronic liver disease distinct from 
acute liver failure and decompensated chronic liver 
disease[1].Asia Pacific Association for the Study of 
the Liver (APASL) defined it as “acute hepatic 
insult manifesting as jaundice (defined as serum 
bilirubin level ≥5 mg/dL) and coagulopathy 
(defined as international normalized ratio ≥1.5),  
complicated  within  4  weeks  by  ascites  and/or  
encephalopathy  in  a patient with previously  
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diagnosed or undiagnosed chronic liver disease 
[2].ACLF occurs in about 30% of patients with an 
acute decompensation of cirrhosis[3]. and it has a 
significantly higher short-term mortality of 30-50% 
than expected with decompensated liver cirrhosis[3-
5].Multiple organ failure and an increased mortality 
risk are key to the diagnosis of ACLF. The 
occurrence of organ failure(s) in patients with 
cirrhosis indicates a dismal prognosis. It is usually 
associated  with  a  precipitating  event  which  can  
be  reversed  if diagnosed early, although the 
underlying cirrhosis is irreversible. ACLF constitutes 
about 30-35% of all admissions and about 50% of all 
liver failures admitted in dedicated liver units in 
tertiary care setup[3-5]The causes of acute insult in 
ACLF are variable and depend mainly on the 
geographical area and the population under study, 
and they can be  both infectious and non 
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infectious. In some patients with ACLF, there may be 
simultaneous presence of more than one acute 
insult. Data on ACLF is scarce, heterogeneous, 
and mostly retrospective. The present study was 
chosen to look into the various etiologies of 
acute precipitating  events,  the  underlying  chronic  
liver  disease,  the  clinical  and biochemical 
spectrum and also the factors predicting mortality in 
ACLF patients of  this region. Lack of a unifying 
definition causes difficulty in  comparison studies. 
This study was taken up in a government run tertiary 
care centre with adequate facilities for necessary 
investigations and treatment of ACLF patients. 
Management consists of general supportive measures, 
treatment of underlying infection if present and 
treatment of underlying etiology of chronic and acute 
liver disease if possible. Currently ACLF patients do 
not have a priority in liver transplant listing and often 
these patients are considered too sick for the surgery. 
 
Materials and Methods 
 
 This prospective observational study was conducted 
in Department of Medical Gastroenterology, Osmania 
Medical College and General Hospital, Hyderabad. 
Consecutive patients of acute on chronic liver 
failure were enrolled in this study. The study 
period was from November 2013 to December 2015.  
Inclusion criteria: Consecutive patients with ACLF 
as defined by APASL were included. These patients 
may have either previously diagnosed or undiagnosed 
compensated  cirrhosis.  The diagnosis of cirrhosis of  
liver  was  based  on previous liver biopsy findings if 
available or based on clinical, imaging (heterogenous 
echotexture of liver with irregular outline, altered liver 
size, or portosystemic collaterals), laboratory (low 
serum albumin, aspartate aminotransferase/alanine 
aminotransferase ratio > 1) and endoscopic findings 
(oesophageal varices > 5mm).  
Exclusion criteria: Age less than 18 years or more 
than 80 years, Hepatocellular carcinoma, Portal vein 
thrombosis, Patients with any disseminated 
malignancy, HIV/ AIDS, Pregnant women, Previously 
decompensated cirrhosis and Acute liver failure.  
Assessment of severity and organ dysfunction: 
Severity assessment scores -Child –Turcotte-Pugh 
(Table 2), MELD and modified SOFA score were 
calculated for all patients (Table 3). MELD score is 
calculated as follows -logarithmic equation (0.957 
× log [creatinine mg/dl]+0.378 × log [bilirubin 
mg/dl] + 1.120 × log [international normalized 
ratio] +0.643). Presence or absence of Systemic 
Inflammatory response syndrome  (SIRS) was noted. 
Maddrey's Discriminant function (MDF) was 
calculated  in  patients  who  had  alcoholic  liver  
disease  as  follows:  [4.6×(patient’s prothrombin 
time - control prothrombin time, in seconds)] + serum 
bilirubin level, in milligrams per deciliter. These 
scores were calculated at baseline and also repeated 
at weekly intervals. Organ failure was defined by 
the presence of SOFA score of 3 or more for the 
respective organ system. Presence of two or more 
extra hepatic organ failure is defined as multiorgan 
failure. Systemic Inflammatory response syndrome  
(SIRS): Evidence of a systemic response to infection 
defined by the presence of two or more of the 
following signs namely 
 Fever ( temperature >38.30 
C) or hypothermia (rectal temperature <35.60 C). 
Tachycardia (heart rate >90 beats/min). Tachypnea 
(respiratory rate >20 breaths/min or PaCO2 <32 
mmHg) or need for invasive mechanical ventilation. 
Alteration of the white cell count > 12,000 
cells/mm3,<4,000 cells/mm3 or >10% immature 
neutrophils (bands) 
 
Table 1: Severity assessment scores -Child –Turcotte-Pugh 
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Table 2: Shows SOFA Score ( Sequential organ failure) 
 
SOFA 0 1 2 3 4 
RESPIRATION 
PaO2/FIO2( 
mm Hg) 
>40
0
 
≤400
 
≤300
 
≤200
 
≤100
 
 
pulse 
oximet er 
oxygen 
saturati on 
(SpO2) 
*
 
 
SpO2 
>90% 
 
at 
room 
air 
SpO2 
 
≤90% at 
room 
air, 
increase 
d above
 
90% 
with 
FiO2 
0.24 
(1 
L/min 
nasal 
O2) 
 
 
 
 
SpO2 
≤90% at 
room air, 
increased 
above 90% 
with 
 
FiO2 
0.30 
(ma
sk 
)
 
 
 
 
 
SpO2 ≤90% 
at room air, 
 
increased above 
 
90% 
 
with FiO2 
0.50 
(mas
k) 
 
 
 
 
SpO2 ≤90% at room 
air and despite FiO2 
 
0.50 (mask) 
COAGULATION 
Platelets 
×103/mm3 
>150
 
≤150
 
≤100
 
≤50
 
≤20
 
LIVER 
Bilirubin(mg 
/dl) 
<1.2
 
1.2–1.9
 
2.0–5.9
 
6.0–11.9
 
>12.0
 
CARDIOVASCULAR 
 
 
Hypotensio n 
 
 
No 
hypot
ensio 
n 
 
 
MAP 
<70 mm 
Hg 
 
Dopamine ≤ 
5 or 
dobutamin
e (any 
dose) 
Dopamine >5 or
 
epinephrine ≤ 
0.1 or 
norepinephrine 
 
≤ 0.1 
Dopamine >15 or
 
epinephrine >0.1 or 
norepinephrine 
 
>0.1 
CENTRAL NERVOUS SYSTEM 
Glasgow 
Coma Score 
 
 
15 
 
 
13–14 
 
 
10–12 
 
 
6–9 
 
 
<6 
RENAL  
Creatinine 
mg/dL <1.2 1.2–1.9 2.0–3.4 3.5–4.9 >5.0 
(µmol/ L) 
or 
(<11
0)
 
(110–
 
170) 
(171–299)
 (300–440) or 
<500 mL/day 
(>440) or 
<200 
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Respiratory failure is defined by a SOFA score ≥3 or requirement for mechanical ventilation; 
hematologic failure by a score of 4 and/or INR >2.5; liver failure by a score of 4; cardiovascular 
failure by a score ≥2;neurologic failure by a West Haven score ≥3 or requirement for 
endotracheal intubation to prevent aspiration 
pneumonia; renal failure by a score ≥2 or requirement for renal-replacement therapy.
 
 
Results:  
A total of 50 cases are enrolled in study of acute on chronic liver failure  
 
Table 3: Shows the distribution based on age and sex 
 
Age group in yrs
 
Cases
 
 No.
 
%
 
≤ 20 yrs
 
2
 
4
 
21 – 30 yrs
 
6
 
12
 
31- 40 yrs
 
17
 
34
 
41 – 50 yrs 18 36 
51 – 60 yrs
 
6
 
12
 
≥ 61 1 2 
Total
 
50
 
100
 
Mean ± SD
 
40.88 ± 1.1
 
Sex 
Female 8 16 
Male 42 84 
Total 50 100 
 
Table 3 shows that in the present study it was observed that the mean age in cases was 40.88 yrs. In the present 
study it was observed that 84 % of patients were male and 16% patients were females. The ratio between male: 
female was 5.25: 1. 
 
Table 4: Shows clinical features in all patients 
 
Clinical Features
 
Number
 
Percentage
 
Jaundice
 
50
 
100
 
Ascites
 
50
 
100
 
Mean duration of
 
symptoms 
23.2
 
10 – 30
 
Encephalopathy
 
30
 
60
 
Grade ≥ 2
 
encephalopathy 
20
 
40
 
Upper GI bleeding
 
5
 
10
 
Large esophageal varices
 
16
 
32
 
Portal hypertensive
 
gastropathy 
17
 
34
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Hepatomegaly
 
23
 
46
 
Spleenomegaly
 
32
 
64
 
Asterixis
 
12
 
24
 
Parotid enlargement
 
14
 
28
 
SIRS
 
28
 
56
 
 
Table 4 shows that acute onset of jaundice with ascites was seen in all the 50 patients. Most patients had severe 
jaundice with a median of 12.5 mg/dl (range between 5.9 – 36.9).  
 
Table 5: Shows laboratory findings in all patients and features of sepsis 
 
Laboratory findings
 
Median
 
Percentage
 
WBC
 
11400
 
5100 – 26400
 
HB (gm/dl)
 
10
 
5 – 13.2
 
Platelet count
 
110000
 
12500 – 200000
 
RBS (mg/dl)
 
101
 
40 – 176
 
Blood urea (mg/dl)
 
34
 
18 – 302
 
Creatinine (mg/dl)
 
1
 
0.6 – 4.8
 
Na+
 
134
 
114 – 148
 
K+
 
3.9
 
2.0 – 6.2
 
t. bilirubin (mg/dl)
 
12.5
 
5.9 – 36.9
 
AST (IU/L)
 
86.5
 
22 – 1501
 
ALT (IU/L)
 
124.5
 
26 – 1085
 
ALP
 
115
 
32 – 588
 
Total Protein (gm/dl)
 
5.8
 
4.5 – 7.8
 
Albumin (gm/dl)
 
2.5
 
1.8 – 3.5
 
PT (sec)
 
20
 
16 – 60
 
INR
 
1.8
 
1.6 – 6
 
CRP (mg/dl)
 
48
 
2 – 102
 
MDF
 
99.6
 
54.28 – 201.5
 
MELD
 
26.5
 
19 – 41
 
SOFA
 
7
 
3 – 14
 
CTP
 
11.5
 
9 – 15
 
Features of sepsis 
Elevated WBC 25 50 
Fever 24 48 
Elevated CRP 30 60 
SIRS 28 56 
Documented Sepsis 16 32 
Sepsis was seen in 16 patients. Among the patients with documented sepsis 4 patients survived and 12 died. All 
 Asian Pac. J. Health Sci., 2016; 3 (2):47-57                                             e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________
Sumana P V et al                            ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2016; 3(2): 47-57 
www.apjhs.com      52 
 
patients had elevated CRP except 2 (4%).Median values was 48 mg/dl (range 2 – 102). 
Aetiology of chronic liver disease and reasons for acute exacerbation was evaluated. Most common cause of 
underlying liver disease is alcoholic liver disease (76 %) followed by hepatitis B (6 %) there were 5 patients 
(13.2%) in whom cause for acute deterioration could not be found. Among the alcoholic liver disease super 
added alcoholic hepatitis is the most common (36.8%) cause followed by acute hepatitis E (18.4%). Most 
patients were actively drinking alcohol almost till few days before admission. Among patients with chronic 
hepatitis B, reactivation of hepatitis B is the most common cause. There were two patients with autoimmune 
liver disease  whose  cause  of  deterioration  was  AIH  flare.  In  one  patient  with Wilsons disease cause for 
acute deterioration was acute Hepatitis E.In one case of crytogenic the cause of deterioration was was drug 
induced, in two patients of Budd chiari syndrome cause of deterioration was hepatitis A infection in one patient 
and urinary tract infection in other, in two patients of HCV cause of deterioration was alcoholic hepatitis in 
one patient and Hepatitis E infection in other. 
 
Table 6: Shows comparison of various laboratory parameters 
 
Laboratory
 
Parameters
 
Survivors
 
Dead
 
t value
 
p value
 
 Mean
 
SD
 
Mean
 
SD
 
WBC
 
10247.8
 
3967.8
 
12322.2
 
5164.2
 
1.5
 
0.123
 
HB (gm/dl)
 
10.1
 
1.9
 
9.5
 
2
 
1.11
 
0.27
 
Platelet count
 
117934.8
 
36809.2
 
103666.7
 
28952.2
 
1.53
 
0.13
 
RBS (mg/dl)
 
104.6
 
17.6
 
109.6
 
30.1
 
0.69
 
0.49
 
Blood urea (mg/dl)
 
38.04
 
21.6
 
73.6
 
66.5
 
2.4
 
0.018
 
Creatinine (mg/dl)
 
1.05
 
0.85
 
1.75
 
1.2
 
2.3
 
0.02
 
Na+
 
133.3
 
7.6
 
132.5
 
8.9
 
0.35
 
0.73
 
K+
 
3.95
 
0.72
 
3.5
 
1.08
 
1.4
 
0.15
 
T. bilirubin (mg/dl)
 
12.7
 
6.3
 
15.8
 
7.9
 
1.5
 
0.13
 
AST (IU/L)
 
121.5
 
118.2
 
194.2
 
299.2
 
1.09
 
0.27
 
ALT (IU/L)
 
144.1
 
69.9
 
223.7
 
232
 
1.58
 
0.12
 
ALP
 
156.3
 
92
 
189.4
 
159.7
 
0.87
 
0.38
 
Total Protein
 
(gm/dl) 
6.01
 
0.7
 
5.8
 
0.7
 
0.7
 
0.4
 
Albumin (gm/dl)
 
2.5
 
0.48
 
2.5
 
0.37
 
0.4
 
0.68
 
PT (sec)
 
19.65
 
2
 
25.7
 
8.6
 
3.26
 
0.002
 
INR
 
1.7
 
0.11
 
2.5
 
0.95
 
4.02
 
<0.001
 
CRP (mg/dl)
 
32
 
16.2
 
76
 
21.9
 
7.9
 
<0.001
 
MDF
 
84.9
 
41.5
 
126.9
 
37
 
2.12
 
0.05
 
MELD
 
22.9
 
4.1
 
30.5
 
6.1
 
5.06
 
<0.001
 
SOFA
 
5.6
 
1.7
 
9.6
 
2
 
7.4
 
<0.001
 
Table 6 shows that in  the  present  study  it  was  observed  that  mean  Blood  urea,  Creatinine, prothrombin 
time, INR and CRP was significantly higher in the patients who died compared to patients who survived. 
P<0.05. 
In the present study it was observed that 3.7 % of patients who died had 3 organ failure 18.5 % of patients 
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who died had 2 organ failure compared to 4.3 % patients who survived. 77.8 % of patients who died had 1 organ 
failure compared to 95.7 % patients who survived. There was no statistical significant association between death 
and no. of organ failures.19 patients died within two weeks. So 14 day mortality was 28% another 8 patient died in 
the next two weeks So the expected 90 day mortality was 54 % (27/50). Of all the patients who died 26 patients 
had organ failure. The mean time from hospital admission to death was 12.5 days (4-37 days). The ability of 
various scoring systems like SOFA score, MELD and CTP score was assessed to predict mortality between 
survivors and non survivors using area under receiver operating curve. AUROC was significantly higher for SOFA 
and (.932) score compared to MELD (.857) CTP score (.858).MELD score of 36 has a sensitivity of 25.9% and 
specificity of 100 % in predicting mortality. SOFA score of 7.5 has a sensitivity of 81.5% and specificity of 91.3 % 
in predicting mortality. CTP score of 11.5 has a sensitivity of 81.5% and specificity of 87 % in detecting mortality. 
CRP levels of 76 has a sensitivity of 63% and specificity of 100 % in predicting mortality. PT value of 24.5 has a 
sensitivity of 55.6 % and specificity of 95.7 % in  predicting mortality.  INR value of 24.5 has a sensitivity of 63 % 
and specificity of 100 % in predicting mortality.  
 
Discussion 
 
This prospective observational study was done to look 
into the clinical profile, precipitating factors, 
prognostic factors and outcome in acute on chronic 
liver failure patients presenting to a tertiary care 
centre. ACLF is a unique entity with a rapidly 
deteriorating course but with a potential for 
reversibility if diagnosed and treated early. ACLF 
constitutes about 30-35% of all admissions and about 
50% of all liver failures admitted to dedicate liver 
units in tertiary care centers. Multiple organ failure 
and an increased mortality risk are key to the 
diagnosis of ACLF. As defined by APASL guidelines 
all patients in this study had jaundice and 
coagulopathy. Investigations for etiology of 
underlying chronic liver disease and cause of acute 
deterioration were performed as required on an 
individual case based approach.  
Age Distribution: In this study it was observed that 
the mean age with standard deviation in cases was 
40.88 ± 1.1 yrs. Majority of patients in the study 
group were in the age group of 41 – 50 yrs (36%) 
followed by 31 – 40 yrs (34%), 21 – 30 yrs (12%), 51 
– 60 yrs (12%). The median age of the patients was 36 
(range 15 to 80) years in a large prospective study 
done by H.Garg et al in Delhi[6].  In a study done by 
Khatun UF et al7 majority of the patients were 
between 45-54 years. Dhiman RK et al reported in 
their study that the mean age with standard deviation 
was 46 ± 13 years in ACLF patients[8].The median 
age was 53 years in a study reported by Deepak 
amarapurkar et al.  
Sex Distribution
:In the present study it was observed 
that 84 % of patients were male and 16% were female. 
The ratio between male: female was 5.25 : 1. Male 
patients consisted of 74%, 86%, 86%, 81.8% in 
studies by H Garg et al [6] Khatun UF et al 
[7],Dhiman RK et al [8],Deepak amarapurkar et al 
[9].respectively. The sex distribution of ACLF 
patients is similar to that of in cirrhotic patients 
presenting to our hospital.  
Clinical Presentation: Jaundice was present in all 
50(100%) cases and was severe in most patients with 
a median of 12.5 mg/dl ( range  5.9 – 36.9) .  H Garg 
et al6 study showed a median bilirubin of 23.1mg/dl, 
Dhiman RK et al  study showed a median bilirubin 
of 13.2 mg/dl and Deepak amarapurkar et al study 
showed a mean serum bilirubin of 11.3+/- 8.7 mg/dl. 
Ascites was seen in all 50 patients  but grade  3  
ascites  according to  the International Ascites Club 
Classification was seen in 10(20%) patients. 
Encephalopathy was seen in 30 (60%) patients in this 
study. Khatun UF et al showed that encephalopathy 
was present in all cases (100%) whereas 
encephalopathy was present in only 34% in a studies 
by H Garg et al and Dhiman RK et al. Out of 30 
patients with hepatic encephalopathy in this study, 20 
patients had grade 2 or grade 3 encephalopathy. Non 
survivors had higher grades of hepatic 
encephalopathy when compared to survivors. Acute 
hepatic encephalopathy was defined as acute change 
in metal status in the absence of other acute 
neurological disease, either as first episode or 
recurrence i n  a  p r e v i o u s l y  t r ea t ed  p a t i e n t .  
Worsening o f  c h r o n i c   hepatic encephalopathy 
was not considered as acute decompensation. The 
mean duration of symptoms in this study was 23.2 
(10-30) days.Hepatomegaly was seen in 46% in  the 
present study. In a study by H Garg et al 
hepatomegaly was seen in 53% patients . 
Splenomegaly was present  in 64%  patients  in  
this  study  whereas  in  the  study  by  H  Garg  et  
al splenomegaly was seen in only 12% . In this study 
astrexis was seen in 24% and parotid enlargement in 
28% of the cases. Spider naevi were seen in only 3 
 Asian Pac. J. Health Sci., 2016; 3 (2):47-57                                             e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________
Sumana P V et al                            ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2016; 3(2): 47-57 
www.apjhs.com      54 
 
patients and only 2 male patients had gynaecomastia. 
Large varices were seen in 16(32%), PHG in 17(34%) 
patients but only 5(10%) patients in this study 
developed upper gastrointestinal bleed after the 
symptom onset and it was mild to moderate which 
responded to medical and endoscopic management. 
Upper gastrointestinal tract bleeding was seen in 
4.4% in a study by H Garg et al and 13.33% in a 
study by Khatun UF et al. There is a controversy 
regarding including gastrointestinal bleeding as an 
acute precipitant. No consensus has been reached 
about including gastrointestinal bleeding as an acute 
event by the APASL consensus committee[2].. Based 
on this study an observation, bleeding was probably 
due to coagulopathy and stress and may not be a 
trigger for acute deterioration.  
Chronic Liver Disease: Two thirds of the patients 
had a previous history of chronic liver disease 
whereas about a third  of  patients had  no 
previous history of  chronic liver disease. The most 
common cause of chronic liver disease in this 
study was alcoholic liver disease (76%). Most 
western studies have shown alcohol as the most 
common etiology followed by viral hepatitis. In a 
large prospective study by H Garg et al chronic 
hepatitis B (37%) followed by alcohol (34%) and 
cryptogenic cirrhosis were the common causes of 
underlying chronic liver disease. Duseja et al from 
Chandigarh found alcohol as the most common insult 
followed by viral hepatitis and autoimmune hepatitis5. 
Dhiman RK et al  from chandigarh reported that 
alcoholic liver disease (68%) was the most common 
etiology of cirrhosis in ACLF. Khatun UF et al from 
bangladesh reported in their study that common 
causes of chronic liver diseases were hepatitis B 
(50%), hepatitis C (26.67%) and alcohol (16.67%). 
Deepak Amarapurkar et al  showed in their study that 
alcohol as a primary etiology for cirrhosis was present 
in 25 (56.8 %) patients, followed by 
cryptogenic/NASH in 12 (27.2 %) patients. Most of 
the patients presenting with compensated and 
decompensated cirrhosis in our department are 
alcohol related and similar trend was seen in ACLF 
patients too.  
Acute Precipitating Insult: Alcohol was the most 
common acute precipitant (36.8%) in underlying 
alcoholic liver disease in our study. Dhiman RK et al 
in their study showed active alcohol intake as the 
acute precipitating event in 40% of their cases . In a 
study by Deepak Amarapurkar et al 25% of the acute 
insults was due to alcohol. Alcohol as an acute insult 
was considered if the patient had his last drink within 
28 days preceding the symptoms. After the direct 
hepatic injury, the immunologic injury starts to 
decline[10], so a period of 28 days was considered 
adequate for inclusion as the last drink. Active 
alcoholism was defined as alcohol consumption 
within the previous 3 months in a study by Dhiman 
RK et al.In alcoholic hepatitis, elevated interleukin 
(IL)-18 levels result in neutrophil accumulation in 
the liver with subsequent release of reactive oxygen 
species resulting in hepatocyte injury. Acute ethanol 
ingestion may also result in a suppressed  T-cell  
response,  decreased  monocyte  function,  and  
increased levels  of  IL-1  and  IL-6.  Severity  of  
alcoholic  hepatitis  was  calculated  by Maddrey 
discriminant function  (MDF)  as  4.6  x  [patient’s  
prothrombin  time- control prothrombin time] + total 
bilirubin(mg/dl). They were managed by 
pentoxyfylline 400mg thrice daily in addition to other 
routine treatment.Hepatitis E virus accounted to 
18.4% of acute insults in patients with underlying 
chronic alcoholic liver disease, whereas infection 
with pneumonia, SBP, UTI and cholangitis together 
accounted to 21.1%. Patients with alcoholic liver 
disease are more prone for infection and its 
complications. Mookerjee et al observed that these 
patients have defective neutrophil function and 
phagocytosis[11]. These neutrophils show increased 
oxidative burst depicting a functional failure. In all 3 
patients with chronic hepatitis B, reactivation of 
hepatitis B was the cause of acute deterioration 
(100%). The diagnosis of hepatitis B virus (HBV) 
flare was based on the American Association for the 
Study of Liver Diseases (AASLD) practice 
guidelines. In a study by H Garg et al  reactivation 
of hepatitis B was seen in 85% patients whereas in a 
study by Dhiman RK et al reactivation of hepatitis B 
was seen in only 4% . Our findings were similar to 
findings published in other studies  they were started 
on antiviral Tenofovir 300mg once daily modified 
according to the renal function of the patient. Acute 
hepatitis E as a cause of deterioration was seen in 
10(20%) patients. In a study from Acharya et al 
from Delhi published in 2007 HEV was positive in 
50%  of  patients  with  acute  deterioration12.Most  
studies  from  Indian subcontinent have found acute 
hepatitis E in 40-60% of patients. However these 
studies cannot be directly compared as the diagnosis 
of ACLF has not been clearly defined. HAV was the 
acute precipitating event in 3(6%) patients in this 
study. Most studies from India did not show HAV as 
a precipitating event, this disperancy may be due to 
geographical and socioeconomic factors. Acute viral 
hepatitis was diagnosed based on compatible clinical 
presentation, liver function tests and a positive 
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serology for hepatitis E virus (IgM anti-HEV) or 
hepatitis A virus (IgM anti-HAV) by ELISA). In two 
patients with underlying chronic hepatitis C the 
reason for acute decompensation was alcohol in 
one and HEV in the other. Transaminases were 
elevated in both patients and HCV RNA levels 
were low. Both patients with HCV were genotype 3.  
Sepsis: History of fever was present in 24(48%) and 
elevated WBC count was present in 25(50%) patients. 
The median white blood cell (WBC count) in the 
present study was 11400. In a study by H.Garg et al 
the median WBC count was 12.3 (range 3.1 to 
40.8)×103 cells/mm3. Even though these two 
features are suggestive of sepsis, it could be 
documented in only 32% of our patients. Due to the 
hyperdynamic circulation and complications of portal 
hypertension, the currently accepted clinical definition 
of SIRS and hence sepsis may not be entirely 
applicable to patients with cirrhosis or ACLF. Hence, 
a high index of suspicion is required for making a 
clinical diagnosis of sepsis in these patients. Two 
patients had drug induced liver injury and two 
patients had a flare of autoimmune hepatitis as their 
precipitating event. The diagnosis of autoimmune 
hepatitis (AIH) was based on the simplified 
criteria for AIN[13]..No definitive cause of acute 
deterioration could be found in 5(10%) patients. In a 
study by H Garg et al definitive cause of an acute 
insult was not found in15( 16.48%) patients .In a 
study by KhatunUF et al  from Bangladesh unknown 
acute events were 30%.  
Laboratory Findings: The median hemoglobin was 
10 gm/dl (range 5 – 13.2).The median platelets were 
110000/cu mm (12500 – 900000). Median AST 
and ALT values were 86.5 and 124.5 IU/L .Median 
Total Protein was 5.8 gm/dl (4.5 – 7.8), albumin 
values were low 2.5 gm/dl (1.8- 3.5). INR was 
prolonged (median 1.8, range1.6- 6). INR was more 
than 2.5 in 9 patients (18%). Median MDF was 99.6 
(54.28 – 201.5),  MELD score was 26.5 (19 – 41), 
SOFA 7 (3 – 14) and CTP was 11.5 (9 – 15).  
 Organ Failure: Single organ failure was seen in 22 
patients who survived and in 21 patients who died. 
Only one patient with 2 failed organ responded to 
treatment and survived, while 5 patients with two 
organ failures died. There was only one patient with 3 
or more organ failures and he did not survive. 
Though there was a clinical significance between no 
of organs failed and mortality, a statistical 
significance couldn’t be reached . In a large 
prospective study done by H Garget al from 
delhi.one-third patients had multi organ failure. 
The course of ACLF was found to be quite rapid and 
within one week of presentation, more than 1 0 %  
patients  died  ofmulti  organ  failure.  In a   study  
by  Deepak amarapurkar et al  50 patients (80.6 %) 
had at least 1 organ failure whereas 15 had ≥3 organ 
failures (mortality rate >75 %). One of the important 
features of ACLF is the development of organ failure. 
Presence of two or more extra hepatic organ failures is 
considered multi organ failure.  
Mortality: Out of 50 patients in our study, 27(54%) 
died. Few patients were referred for transplantation 
but because of financial constraints, transplant was not 
feasible. This mortality rate is similar to mortality in 
other published studies. However it is lesser than the 
mortality seen in the study by H Garg et al. The mean 
time from hospital admission to death was 12.5 days 
(4-37). Nine (33.33%) patients died within first week 
and another 10 patients died (37.03%) in the second 
week. 19 of the 27 patients who died (70.37%) died 
within the initial two weeks. These findings show that 
initial two weeks is very critical in the management of 
these patients. ‘‘Golden window’’ is a short period 
of about 1 week before the onset of sepsis and 
development of extra-hepatic organ failure in a 
patient with ACLF. Early diagnosis and therapeutic 
interventions during this period are likely to prevent 
organ failure and provide a potential opportunity for 
reversing the hepatic injury. This importance of initial 
two weeks has been highlighted in other studies. In a 
large proportion of ACLF patients liver transplant is 
not feasible, due to the lack of an organ or a donor, 
severity of the illness, or other socio economic 
challenges. Garg et al14 have shown that granulocyte 
colony- stimulating factor (G-CSF) can mobilize bone 
marrow-derived CD34 + cells which help in hepatic 
regeneration. In addition, it was shown to 
significantly reduce the development of sepsis and 
subsequent multi organ failure. A study from the East 
in patients with HBV-related ACLF has 
substantiated the role of G-CSF. However, despite 
the encouraging results presently routine use of these 
agents is not yet recommended.  
Predictors of mortality: In the present study it was 
observed that mean blood urea, serum creatinine, 
prothrombin time, INR and CRP was significantly 
higher in the patients who died compared to patients 
who survived p<0.05. CRP levels of 76 has a 
sensitivity of 63% and specificity of 100 % in 
predicting mortality in this study.In the present study, 
PT value of 24.5 has a sensitivity of 55.6 % and 
specificity of 95.7 % in predicting mortality. INR  
value  of  24.5  has  a  sensitivity of  63  %  and  
specificity of  100  %  in predicting mortality. The 
ability of various scoring systems like SOFA score, 
MELD and CTP score was assessed to predict 
 Asian Pac. J. Health Sci., 2016; 3 (2):47-57                                             e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________
Sumana P V et al                            ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2016; 3(2): 47-57 
www.apjhs.com      56 
 
mortality between survivors and non survivors using 
area under receiver operating curve. AUROC was 
significantly higher for SOFA (.932) score compared 
to MELD (.857) and CTP score (.858). H.Garg et al 
showed that amongst all severity scores studied, 
MELD, SOFA and APACHE-II scores had AUROCs 
of >0.8 which was significantly higher than that of 
Child-Turcotte–Pugh score. In this study MELD score 
of 36 has a sensitivity of 25.9% and specificity of 100 
% in predicting mortality. SOFA score of 7.5 has a 
sensitivity of 81.5% and specificity of  91.3 % in 
predicting mortality  and  CTP score of 11.5  has a 
sensitivity of 81.5% and specificity of 87 % in 
detecting mortality. There are no prospectively 
validated scoring systems for ACLF. For critically ill 
cirrhotic patients admitted to ICU with multi-organ 
failure, SOFA appears to be the  best  prognostic  
model  (AUC  0.84).In  ACLF-B  patients,  liver-
specific models are described and perform 
reasonably well, namely MELD, modifications of 
MELD (AUC 0.7–0.84), and logistic regression 
models (AUC 0.844–0.891). In cirrhotics with acute 
decompensation, CLIF– SOFA score has been  
validated  in  Europe  but  it  remains  to  be  
prospectively  evaluated  in patients with ACLF, 
where liver failure is the predominant presentation.  It 
has generally been shown that MELD and SOFA 
scores are better predictors of mortality than Child 
score and APACHE score . 
  
Conclusion 
 
ACLF is characterized by rapidly deteriorating 
course in a previously      diagnosed or undiagnosed 
chronic liver disease with a potential for reversibility 
It has generally been shown that MELD and SOFA 
scores are better predictors of mortality than Child 
score and APACHE score . 
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